News for Lucira Health, Inc. (LHDX)

The global rapid influenza diagnostic test market is growing at a CAGR of 9.8% during 2022–2030....

The waning of the COVID-19 pandemic is reshaping the healthcare industry once again. Vaccine makers and pharmacy chains are seeing a decline in the number of people getting COVID shots, while makers of at-home rapid tests are going out of business. Companies that produced personal protective equipment have also shut down. The shift in demand is evident as Pfizer cuts $9 billion from its annual sales forecast due to declining demand for its COVID shots. While some healthcare businesses are benefiting from the return of routine checkups and procedures, others are feeling the pressure to adjust their expectations.

Labcorp is a clinical laboratory network. Who are Labcorp’s competitors and alternatives? Quest, ARUP, BioReference, Pfizer, Sonic, Charles River, Myriad, and NeoGenomics. Read more.

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced...

/PRNewswire/ -- The

/PRNewswire/ -- The point of care molecular diagnostics industry is poised for significant growth and advancements in the near future. With the increasing...

Aditxt,® Inc, , a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three... | April 17, 2023

NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrant of Core Scientific, Inc. Core Scientific, Inc. securities were suspended on January

This is a summary of a request from Lucira Health Inc. to hire Cooley LLP as lead counsel, filed March 22 with the U.S. Bankruptcy Court in Wilmington, Del.

Combination Test Also Secures Point-Of-Care Authorization in AustraliaLab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but... | March 28, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

During Thursday, 166 stocks hit new 52-week lows. 52-Week Low Highlights: Alibaba Group Holding (NYSE:BABA) was the largest firm on a market cap ...

GuruFocus Article or News written by GuruFocusNews and the topic is about:

/PRNewswire/ -- According to the new market research report "Point of Care Molecular Diagnostics Market by Product (Assays, Kits, Analyzers, Service),...

Gainers Society Pass Incorporated (NASDAQ:SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. (NASDAQ:ACST) jumped 52...

Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that th...

Here's a roundup of top developments in the biotech space over the last 24 hours: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...